KEZAR LIFE SCIENCES INC. news, videos and press releases
For more news please use our advanced search feature.
KEZAR LIFE SCIENCES INC. - More news...
KEZAR LIFE SCIENCES INC. - More news...
- Kezar Life Sciences to Participate in Cowen 42nd Annual Health Care Conference
- Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
- Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants
- Kezar Announces Proposed Public Offering of Common Stock
- Kezar Provides Data Update from MISSION Study of KZR-616
- Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference
- Kezar Announces Presentations During Upcoming Scientific Conferences
- Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
- Kezar Life Sciences Strengthens Executive Team with the Appointment of Noreen R. Henig, MD as Chief Medical Officer
- Kezar Provides Statement Regarding COVID-19 Pandemic
- Kezar Life Sciences Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update
- Kezar Life Sciences to Present at Cowen and Company’s 40th Annual Healthcare Conference
- Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
- Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
- Kezar Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors
- Kezar Life Sciences Highlights Therapeutic Potential of Protein Secretion Inhibitors at the 61st American Society of Hematology Annual Meeting
- Kezar Life Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference
- Kezar Life Sciences to Present at Upcoming Investor Conferences
- Kezar Announces Promising New Data with KZR-616 at the American College of Rheumatology Annual Meeting
- Kezar Life Sciences to Host Conference Call and Webcast during the American College of Rheumatology Annual Meeting to Discuss Updated Results with KZR-616
- Kezar Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update
- Kezar Life Sciences Announces Presentations of Four Abstracts at the 2019 ACR/ARP Annual Meeting
- Kezar Life Sciences to Present at the 2019 Cantor Global Healthcare Conference
- Kezar Life Sciences Announces Presentations at Upcoming Investor Conferences
- Kezar Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update
- Kezar Life Sciences Announces Promising Data from First in Patient Study of KZR-616 at EULAR 2019 Annual Meeting
- Kezar Life Sciences to Host Conference Call and Webcast at the EULAR 2019 Annual Meeting to Discuss Results of First in Patient Study with KZR-616
- Kezar Life Sciences Announces Acceptance of Abstract for Presentation of First in Patient Study with KZR-616 at EULAR 2019 Annual Meeting
- Kezar Life Sciences Announces Presentations at Two Upcoming Investor Conferences
